Format

Send to

Choose Destination

An update on publicly funded multisite trials in pediatric psychopharmacology.

Author information

1
National Institute of Mental Health, Room 7147, 6001 Executive Boulevard, MSC 9633, Bethesda, MD 20892-9633, USA. bvitiell@mail.nih.gov

Abstract

In the last 10 years, the National Institute of Mental Health has funded a number of multisite clinical trials in pediatric psychopharmacology. Trials have been completed or are in progress in attention-deficit hyperactivity disorder, depression, autism, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and other anxiety disorders. Direct comparison between different treatment modalities, such as pharmacotherapy and psychotherapy, alone or in combination, has been the focus of a number of these studies, to inform clinicians and families of the relative therapeutic benefits of alternative interventions. This article presents a brief overview of these studies.

PMID:
16321723
DOI:
10.1016/j.chc.2005.08.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center